Healthcare Services

A Significant Growth Driver for the Attention Deficit Hyperactivity Disorder Market Is the The Growing Adoption Of Personalized Medicine Is Driving The Market

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Attention Deficit Hyperactivity Disorder Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The attention deficit hyperactivity disorder market size has seen significant growth in recent years. It is forecast to expand from $17.38 billion in 2025 to $18.55 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.7%. The expansion observed historically can be linked to enhanced awareness of neurodevelopmental disorders, broader diagnostic criteria applicable to various age groups, the accessibility of stimulant medications, the rise of behavioral therapy programs, and a heightened acknowledgment of adhd persistence into adulthood.

The attention deficit hyperactivity disorder market is projected to experience robust expansion in the coming years. This market is anticipated to reach $23.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the forecast period include the rising demand for long-acting medication formulations, an enhanced focus on comprehensive mental health management, the broader availability of telepsychiatry services, increasing investments in digital mental health platforms, and expanded research into non-stimulant therapeutic options. Key trends expected during the forecast period encompass a greater adoption of non-stimulant medications, an uptick in the use of digital therapeutics and monitoring tools, an increasing emphasis on adult ADHD diagnosis, the development of personalized treatment approaches, and improved integration of behavioral and pharmacological therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21108&type=smp

What Major Drivers Are Influencing Demand In The Attention Deficit Hyperactivity Disorder Market?

The increasing acceptance of personalized medicine is anticipated to drive forward the expansion of the attention deficit hyperactivity disorder (ADHD) market. This medical strategy customizes treatments based on a person’s unique genetic, environmental, and lifestyle elements to provide more accurate and impactful healthcare. Its uptake is largely due to progress in genomic technologies, allowing therapies to be specifically designed according to an individual’s genetic makeup, thereby resulting in more efficient and focused interventions. Attention deficit hyperactivity disorder (ADHD) plays a crucial role in personalized medicine, as it helps in developing individualized treatment plans that account for a person’s distinct genetic, environmental, and behavioral traits, leading to more successful and precise treatments. As an example, in February 2024, a report from the Personalized Medicine Coalition (PMC), a US-based non-profit organization, indicated that in 2023, personalized medicines made up over a third of the new FDA drug approvals, marking the fourth consecutive year for this trend. The FDA gave approval to 16 new personalized treatments for rare diseases (an increase from 6 in 2022), along with 7 cancer drugs and 3 for various other ailments. Consequently, the increasing adoption of personalized medicine is fueling the expansion of the attention deficit hyperactivity disorder market.

What Major Segment Divisions Exist Within The Attention Deficit Hyperactivity Disorder Market?

The attention deficit hyperactivity disorder market covered in this report is segmented –

1) By Type: Stimulants, Non-Stimulants

2) By Age Group: Children, Adults

3) By Gender: Male, Female

4) By Dosage Form: Tablets, Capsules, Other Dosage Forms

5) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Online Pharmacy

Subsegments:

1) By Stimulants: Methylphenidate-based Medications, Amphetamine-based Medications, Mixed Amphetamine Salts, Dexmethylphenidate

2) By Non-Stimulants: Atomoxetine (Strattera), Guanfacine (Intuniv), Clonidine (Kapvay)

What Major Market Trends Are Driving Changes In The Attention Deficit Hyperactivity Disorder Market?

Leading companies within the ADHD market are concentrating on developing technological advancements, such as digital therapeutics in the form of video games, to offer non-pharmacological interventions, enhance attention management, and improve patient engagement. A digital therapeutic based on video games provides interactive, adaptive cognitive training via mobile devices, employing real-time performance tracking and closed-loop algorithms to boost focus, attention control, and executive functioning compared to conventional stimulant or non-stimulant medications. For instance, in June 2024, Akili Interactive, a US-based digital health company, released EndeavorOTC, which is the first FDA-cleared over-the-counter digital therapeutic designed for adult ADHD. The product utilizes Akili’s patented “Selective Stimulus Management Engine” to present game tasks that require multitasking and challenge attention, with difficulty levels automatically adjusting based on user performance. A six-week pivotal study indicated that 83% of participants experienced improved attentional control, and users additionally reported enhanced productivity and quality of life.

Which Companies Are Leading Innovation In The Attention Deficit Hyperactivity Disorder Market?

Major companies operating in the attention deficit hyperactivity disorder market are Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis International AG, Eli Lilly and Company, Johnson & Johnson, AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Supernus Pharmaceuticals Inc., Tris Pharma Inc., Mallinckrodt Pharmaceuticals plc, Arbor Pharmaceuticals LLC, KemPharm Inc., Cingulate Therapeutics LLC, Adlon Therapeutics L.P., Ironshore Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals Inc., Alkem Laboratories Ltd.

Read the full attention deficit hyperactivity disorder market report here:

https://www.thebusinessresearchcompany.com/report/attention-deficit-hyperactivity-disorder-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Attention Deficit Hyperactivity Disorder Market?

North America was the largest region in the attention deficit hyperactivity disorder market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the attention deficit hyperactivity disorder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Attention Deficit Hyperactivity Disorder Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21108&type=smp

Browse Through More Reports Similar to the Global Attention Deficit Hyperactivity Disorder Market 2026, By The Business Research Company

Mental Health Apps Global Market Report

https://www.thebusinessresearchcompany.com/report/mental-health-apps-global-market-report

Behavioral Health Software Global Market Report

https://www.thebusinessresearchcompany.com/report/behavioral-health-software-global-market-report

Behavioral And Mental Health Software Global Market Report

https://www.thebusinessresearchcompany.com/report/behavioral-and-mental-health-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795